Stay updated on Tipifarnib in HRAS-Mutant Squamous Head and Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Tipifarnib in HRAS-Mutant Squamous Head and Neck Cancer Clinical Trial page.

Latest updates to the Tipifarnib in HRAS-Mutant Squamous Head and Neck Cancer Clinical Trial page
- Check6 days agoChange DetectedResults data for the study were posted on the page, including outcome measures and updated study record dates. The update provides accessible information on the trial outcomes directly within the study record.SummaryDifference0.4%

- Check13 days agoNo Change Detected
- Check35 days agoChange DetectedAdded a prominent operating-status notice and a new version tag (v3.2.0), replacing the previous version (v3.1.0).SummaryDifference3%

- Check42 days agoChange DetectedUpdated terminology to Squamous cell carcinoma of the head and neck and bumped the revision to v3.1.0, reflecting a terminology update and new version. Earlier term Head and neck squamous cell carcinoma and revision v3.0.2 were removed.SummaryDifference0.6%

- Check57 days agoChange DetectedPage version updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.SummaryDifference0.2%

- Check64 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%

- Check71 days agoChange DetectedThe web page has updated its facility name and location details, adding specific references to various cancers and related resources, while removing some previous location terms and outdated references.SummaryDifference4%

Stay in the know with updates to Tipifarnib in HRAS-Mutant Squamous Head and Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tipifarnib in HRAS-Mutant Squamous Head and Neck Cancer Clinical Trial page.